Asymptomatic Cholesteryl Ester Storage Disease in an Adult Controlled with Simvastatin

Assman G Seedorf U . Acid lipase deficiency: Wolman disease and cholesteryl ester storage disease. In: Scriver CR Beaudet AL Sly WS Valle D , eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 1995: 2563–87.

Scriver CR Beaudet AL Sly WS Valle D . Summary table. In: Beaudet AL Sly WS Valle D , eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 1995: 1–50.

Anderson RA Byrum RS Coates PM Sando GN . Mutations at the lysosomal acid cholesteryl ester hydrolase locus in Wolman disease. Proc Natl Acad Sci USA 1994; 91: 2718–22.

Aslanidis C Klima H Lackner KJ Schmitz G . Genomic organization of the human lysosomal acid lipase gene (LIPA). Genomics 1994; 20: 329–31.

Aslanidis C Ries S Fehringer P Buchler C Klima H Schmitz G . Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. Genomics 1996; 33: 85–93.

Kelly S Bakhru-Kishore R . Fluorimetric assay of acid lipase in human leukocytes. Clin Chim Acta 1979; 97: 239–42.

Ginsberg HN Le NA Short PM Ramakrishnan R Desnick RJ . Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with Lovastatin. J Clin Invest 1987; 80: 1692–7.

Kostner GM Hadorn B Roscher A Zechner R . Plasma lipids and lipoproteins of a patient with cholesteryl ester storage disease. J Inher Metab Dis 1985; 8: 9–12.

Yokoyama S McCoy E . Long-term treatment of a homozygous cholesteryl ester storage disease with combined cholestyramine and Iovastatin. J Inher Metab Dis 1992; 15: 291–2.